NCT02415855View on ClinicalTrials.gov

Canadian Pradaxa Acute Stroke Safety Study

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

May 18, 2018

Conditions
Ischemic Attack, TransientStroke
Interventions
DRUG

Dabigatran

Trial Locations (2)

T6G 2B7

University of Alberta, Edmonton

K1Y 4E9

Ottawa Hospital Research Institute, Ottawa

Sponsors

Collaborators (1)

Boehringer Ingelheim
All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

University of Alberta

OTHER